Company Overview and News

2
Consol Coal Resources Revisited

2018-10-13 seekingalpha
The company has a distribution rate above 10%, which appears well covered as CCR achieved a 1.60 distribution coverage ratio for Q2 2018.
CCR CEIX.WI CNX.WI CNXC CEIX CNX

8
4 Reasons to Add CONSOL Coal Resources to Your Portfolio

2018-10-05 zacks - 1
Earnings estimates for CONSOL Coal Resources LP (CCR - Free Report) have been revised upward in the past 60 days, reflecting analysts’ optimism surrounding the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings has moved up 9.5% and 6.6% to $2.30 and $2.10, respectively, in the said period. CONSOL Coal Resources is a growth-oriented master limited partnership, produces and sells high-Btu thermal coal in the Northern Appalachian Basin and Eastern United States.
ACIIQ CCR CEIX.WI ACI CNX.WI ARCH CNTE YY CEIX CNX

33
Tracking Mason Hawkins' Southeastern Asset Management Portfolio - Q2 2018 Update

2018-09-04 seekingalpha - 1
Mason Hawkins’ 13F portfolio value increased ~10% from $8.17B to $8.95B this quarter. The number of positions remained steady at 28.
SAH CEIX.WI SONC CMCSK SHL CABO BAMGF GE CNX.WI INFY UTX MAT GHC ATU SKHCF GOOGL RLGY INFY BAMKF BATRA PK LSXMB BATRK HCMLY CCV LSXMA CTL BATRR CCZ GOOG LLPFX SKHCY AGN AMR BEN BATRB BEL BIDU BAM CEIX VIPS GEC FWONB CMCSA SOFO FDX FWONA VSAT HCMLF CCV.CL FWONK GNE LSXMK SIMA CNX

112
Tracking David Einhorn's Portfolio - Q2 2018 Update

2018-09-02 seekingalpha - 8
Greenlight's long/short ratio is at 96% long and 75% short compared to 111% long and 82% short last quarter.
TWX AZO MET BLMN DLTR TJX CEIX.WI SFM DSW CLPPZ AABA TWTR VNTR CLPR GLRE CNX.WI ADNT TWC XRX CNDT BHF ROKU GPS ATHN GRBK CCR MDCO NFLX PYPL HUN VOYA ESV ODP AAPL GM CEIX DDS XELA TPR TPX MU DG PRGO TSLA URBN FIVE CNX

2
CNX / CONSOL Energy, Inc. 8-K (Current Report)

2018-08-31 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CNX

3
Reasons to Add Alliance Resource Partners to Your Portfolio

2018-08-24 zacks
Earnings estimates for Alliance Resource Partners, L.P. (ARLP - Free Report) have been revised upward in the past 30 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up 6.1% and 13% to $3.30 and $2.26, respectively in the aforesaid time period. Let’s focus on the factors that make Alliance Resource a profitable pick. Earnings & Growth Projections In second-quarter 2018, Alliance Resource delivered earnings of 64 cents per share, beating the Zacks Consensus Estimate by 1.
ARLP BTU CCR CEIX.WI CNX.WI BTUUQ CEIX CNX

10
Coal Industry Continues to Bounce Back: 5 Stocks in Focus

2018-08-23 zacks
The coal industry has silently staged a comeback from its dark days. In the past 12 months, coal stocks have returned 26.0%, outperforming the Zacks S&P 500 Composite return of 17.6%. The industry has gradually turned around on constructive steps taken by the new U.S. administration along with rising international thermal coal demand. The gradual recovery in metallurgical coal prices is also enhancing the industry’s prospects.
ARLP SOJA SO STZ.B CCR CNX.WI STZ BTU CEIX.WI NRP BTUUQ CEIX CNX

10
4 Reasons to Add CONSOL Energy (CEIX) to Your Portfolio

2018-08-23 zacks
Earnings estimates for Consol Energy Inc. (CEIX - Free Report) have been revised upward in the past 30 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up 0.6% and 3.1% to $5.10 and $3.62, respectively. Let’s focus on the factors that make CONSOL Energy a profitable pick. Earnings & Surprise History In second-quarter 2018, CONSOL Energy delivered earnings of $1.
ARLP SOJA SO STZ.B CCR CNX.WI STZ BTU CEIX.WI BTUUQ CEIX CNX

3
Here's Why You Should Add CONSOL Coal to Your Portfolio

2018-08-22 zacks
Earnings estimates for CONSOL Coal Resources LP (CCR - Free Report) have been revised upward in the past 60 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up 8.2% and 4.2% to $2.10 and $1.97, respectively.
ARLP BTU CCR CEIX.WI TOL CNX.WI BTUUQ CEIX CNX

2
4 Reasons to Add Natural Resource (NRP) to Your Portfolio

2018-08-21 zacks
Estimates for Natural Resource Partners LP (NRP - Free Report) have been revised upward over the past 30 days, reflecting analyst’s confidence in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings has been moved 9.8% and 7.2% north to $4.92 and $5.06 per unit, respectively. Houston, TX-based Natural Resource Partners L.P. is a master limited partnership, principally engaged in the business of owning, managing and leasing mineral reserve properties.
ARLP CCR CEIX.WI CNX.WI NRP CEIX CNX

2
Consol Energy: The Value Half Of A 2-Part Play

2018-08-20 seekingalpha
The combination if higher per ton prices for coal and solid management choices leave this stock plenty of room to grow.
CCR CEIX.WI CNX.WI CEIX CNX

3
4 Reasons Why You Should Invest in Peabody Energy (BTU)

2018-08-16 zacks
Peabody Energy Corporation’s (BTU - Free Report) earnings estimates have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings has also moved up 24.8% and 19.8%, respectively, to $3.62 and $2.54 per share, in the same time frame. Peabody Energy, currently a Zacks Rank #1 (Strong Buy) stock, is a producer of coal, serving power and steel customers in more than 25 countries across six continents.
ARLP BTU CCR CEIX.WI CNX.WI BTUUQ CEIX CNX

21
Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 channelnewsasia
Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry's worst returns, cut back several long-term holdings including Apple Inc , Voya Financial Inc and Consol Energy Inc , a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

22
Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 reuters - 1
BOSTON (Reuters) - Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry’s worst returns, cut back several long-term holdings including Apple Inc (AAPL.O), Voya Financial Inc (VOYA.N) and Consol Energy Inc (CEIX.N), a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

21
RPT-Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 reuters
BOSTON, Aug 14 (Reuters) - Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry’s worst returns, cut back several long-term holdings including Apple Inc, Voya Financial Inc and Consol Energy Inc, a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CNX / CONSOL Energy, Inc. on message board site Silicon Investor.

CNXT the moderated thread CNXT the moderated thread CNXT the moderated thread CONSOL Energy Inc. CONSOL Energy Inc. CONSOL Energy Inc.
Rockwell-Spins off Conexant (CNXT) Rockwell-Spins off Conexant (CNXT) Rockwell-Spins off Conexant (CNXT) CNS Inc. (CNXS) CNS Inc. (CNXS) CNS Inc. (CNXS)
CNXX Centraxx anti-auto theft systems CNXX Centraxx anti-auto theft systems CNXX Centraxx anti-auto theft systems GAAs Fever Arena (RFMD, AHAA, TQNT, ANAD, CLTK, CNXT....) GAAs Fever Arena (RFMD, AHAA, TQNT, ANAD, CLTK, CNXT....) GAAs Fever Arena (RFMD, AHAA, TQNT, ANAD, CLTK, CNXT....)
Nucentrix Broadband (OTC: BB NCNX) Nucentrix Broadband (OTC: BB NCNX) Nucentrix Broadband (OTC: BB NCNX) CNS Inc. (CNXS) Makers of the Breath Right CNS Inc. (CNXS) Makers of the Breath Right CNS Inc. (CNXS) Makers of the Breath Right
CUSIP: 20854P109